• 1
    Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:78599.
  • 2
    Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003;102:18192.
  • 3
    Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367:106674.
  • 4
    Witlin AG, Saade GR, Mattar F, Sibai BM. Predictors of neonatal outcome in woman with severe preeclampsia between 24 and 33 weeks’gestation. Am J Obstet Gynecol 2000;182:60711.
  • 5
    Ganzevoort W, Rep A, de Vries JI, Bonsel GJ, Wolf H; PETRA-investigators. Prediction of maternal complications and adverse infant outcome at admission for temporizing management of early-onset severe hypertensive disorders of pregnancy. Am J Obstet Gynecol 2006;195:495503.
  • 6
    Cnossen JS, ter Riet G, Mol BW, van der Post JA, Leeflang MM, Meads CA, et al. Are tests for predicting pre-eclampsia good enough to make screening viable? A review of reviews and critical appraisal Acta Obstet Gynecol Scand 2009;88:75865.
  • 7
    Hernández-Diaz S, Toh S, Cnattinguis S. Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study. BMJ 2009;338:b2255.
  • 8
    Van Pampus MG, Wolf H, Mayruhu G, Treffers PE, Bleker OP. Long-term follow-up in patients with a history of (H)ELLP syndrome. Hypertens Pregnancy 2001;20:1523.
  • 9
    Van Pampus MG, Wolf H, Weijmar Shultz WC, Neeleman J, Aarnoudse JG. Posttraumatic stress disorder following preeclampsia and HELLP syndorme. J Psychosom Obstet Gynaecol 2004;25:1837.
  • 10
    Rep A, Ganzevoort W, Bonsel GJ, Wolf H, de Vries JI. Psychosocial impact of early-onset hypertensive disorders and related complications in pregnancy. Am J Obstet Gynecol 2007;197:158e16.
  • 11
    Sibai BM, Ramadan MK, Chari RS, Friedman SA. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol 1995;172:1259.
  • 12
    Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IXXIV.
  • 13
    The Netherlands Perinatal Registry [homepage on the internet]. Utrecht: PRN-foundation [Available from:]. Last accessed 1 November 2009.
  • 14
    Langenveld J, Jansen S, van der Post JA, Wolf H, Mol BW, Ganzevoort W. Recurrence risk of a delivery before 34 weeks of pregnancy due to a severe hypertensive disorder: a systematic review. Am J Perinatol 2010;27:56571.
  • 15
    Van Rijn BB, Hoeks LB, Bots ML, Franx A, Bruinse HW. Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. Am J Obstet Gynecol 2006;195:7238.
  • 16
    Sibai BM, Mercer B, Sarinoglu C. Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. Am J Obstet Gynecol 1991;165:140812.
  • 17
    (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994;343:61929.
  • 18
    Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH; Vitamins in Pre-eclampsia (VIP) Trial Consortium. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 2006;367:114554.
  • 19
    Xu H, Perez-Cuevas R, Xiong X, Reyes H, Roy C, Julien P, et al.; INTAPP study group. An international trial of antioxidants in the prevention of preeclampsia (INTAPP). Am J Obstet Gynecol 2010;202:239.e110.
  • 20
    Spinnato JA II, Freire S, Pinto E Silva JL, Cunha Rudge MV, Martins-Costa S, Koch MA, et al. Antioxidant therapy to prevent preeclampsia: a randomized controlled trial. Obstet Gynecol 2007;110:13118.
  • 21
    Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998;338:7015.